TCC Purchases 1.4-acre Medical Site
SEATTLE—Trammell Crow Company has acquired 1124 Columbia Street, a 1.4 acre parcel, which includes a biotech research facility. Report indicates a $42.6M price.
You can now be notified via email if this story is updated by clicking on the "Follow this Story" link. You must be a registered member to take advantage of this "members only" benefit.